GT
GILD icon

Greenleaf Trust’s Gilead Sciences GILD Stock Holding History

Greenleaf Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Sell
24,188
-960
-4% -$126K 0.03% 161
2026
Q1 		$3.5M Buy
25,148
+724
+3% +$101K 0.03% 128
2025
Q4 		$3M Buy
24,424
+1,144
+5% +$139K 0.03% 143
2025
Q3 		$2.58M Buy
23,280
+171
+0.7% +$19.4K 0.02% 161
2025
Q2 		$2.56M Sell
23,109
-5,718
-20% -$609K 0.02% 163
2025
Q1 		$3.23M Buy
28,827
+2,279
+9% +$235K 0.03% 138
2024
Q4 		$2.45M Buy
26,548
+1,351
+5% +$122K 0.02% 164
2024
Q3 		$2.11M Buy
25,197
+2,358
+10% +$180K 0.02% 191
2024
Q2 		$1.57M Sell
22,839
-5,178
-18% -$346K 0.01% 216
2024
Q1 		$2.05M Sell
28,017
-12,474
-31% -$959K 0.02% 178
2023
Q4 		$3.28M Buy
40,491
+2,429
+6% +$189K 0.04% 121
2023
Q3 		$2.85M Sell
38,062
-12
-0% -$923 0.03% 122
2023
Q2 		$2.93M Sell
38,074
-308
-0.8% -$24.6K 0.03% 123
2023
Q1 		$3.18M Buy
38,382
+2,348
+7% +$194K 0.04% 121
2022
Q4 		$3.09M Buy
36,034
+800
+2% +$63.4K 0.04% 120
2022
Q3 		$2.17M Buy
35,234
+12,942
+58% +$816K 0.03% 138
2022
Q2 		$1.38M Buy
22,292
+14,738
+195% +$912K 0.02% 177
2022
Q1 		$449K Sell
7,554
-6,051
-44% -$387K 0.01% 453
2021
Q4 		$988K Buy
13,605
+1,122
+9% +$77.3K 0.01% 251
2021
Q3 		$872K Buy
12,483
+1,700
+16% +$119K 0.01% 250
2021
Q2 		$743K Sell
10,783
-4,327
-29% -$289K 0.01% 295
2021
Q1 		$977K Buy
15,110
+5,374
+55% +$347K 0.01% 213
2020
Q4 		$567K Sell
9,736
-4,478
-32% -$270K 0.01% 301
2020
Q3 		$898K Sell
14,214
-4,599
-24% -$319K 0.01% 178
2020
Q2 		$1.45M Buy
18,813
+612
+3% +$46.9K 0.03% 120
2020
Q1 		$1.36M Sell
18,201
-4,898
-21% -$338K 0.03% 105
2019
Q4 		$1.5M Sell
23,099
-786
-3% -$51.2K 0.02% 126
2019
Q3 		$1.51M Sell
23,885
-590
-2% -$38.6K 0.02% 118
2019
Q2 		$1.65M Buy
24,475
+1,302
+6% +$85.7K 0.03% 110
2019
Q1 		$1.51M Sell
23,173
-1,211
-5% -$80.5K 0.02% 117
2018
Q4 		$1.52M Sell
24,384
-3,050
-11% -$213K 0.03% 105
2018
Q3 		$2.12M Buy
27,434
+1,139
+4% +$86K 0.04% 93
2018
Q2 		$1.86M Buy
26,295
+5,204
+25% +$367K 0.04% 99
2018
Q1 		$1.59M Buy
21,091
+282
+1% +$22.4K 0.03% 108
2017
Q4 		$1.49M Sell
20,809
-235
-1% -$17.8K 0.03% 119
2017
Q3 		$1.71M Sell
21,044
-66,045
-76% -$5.05M 0.04% 108
2017
Q2 		$6.16M Sell
87,089
-3,056
-3% -$203K 0.14% 43
2017
Q1 		$6.12M Buy
90,145
+3,221
+4% +$226K 0.15% 41
2016
Q4 		$6.22M Sell
86,924
-50,018
-37% -$3.72M 0.16% 44
2016
Q3 		$10.8M Sell
136,942
-6,670
-5% -$542K 0.29% 22
2016
Q2 		$12M Sell
143,612
-24,683
-15% -$2.19M 0.31% 16
2016
Q1 		$15.5M Buy
168,295
+1,053
+0.6% +$95K 0.42% 13
2015
Q4 		$16.9M Sell
167,242
-2,126
-1% -$221K 0.51% 15
2015
Q3 		$16.6M Buy
169,368
+7,841
+5% +$871K 0.5% 16
2015
Q2 		$18.9M Buy
+161,527
New +$17.6M 0.55% 15

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Greenleaf Trust's GILD Position: Q2 2026 in Review

Greenleaf Trust reduced its Gilead Sciences (GILD) stake by 3.8% in Q2 2026, selling an estimated $126K and leaving 24,188 shares worth $3.06M. The position accounts for 0.03% of the portfolio, ranked #161.

Greenleaf Trust first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $18.9M in Q2 2015. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Greenleaf Trust held 24,188 shares of Gilead Sciences worth $3.06M as of Q2 2026.
  • Greenleaf Trust sold 960 Gilead Sciences shares in Q2 2026, an estimated $126K.
  • Gilead Sciences made up 0.03% of Greenleaf Trust's portfolio in Q2 2026, its #161 holding.
  • Greenleaf Trust first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
  • Greenleaf Trust's Gilead Sciences position peaked at $18.9M in Q2 2015.
  • 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.